Supplementary Table S1 presents treatment emergent adverse events (AEs) at least possibly related to study treatment
Visible weight loss typically occurs within 23 months
If you are managing semaglutide constipation , dehydration compounds both problems simultaneously
Your appeal should include: A letter of medical necessity from your prescriber citing your BMI, comorbidities, and prior weight-loss attempts Relevant lab work (fasting glucose, HbA1c, lipid panel) that documents obesity-related metabolic dysfunction Reference to the SELECT trial or the STEP program data showing the clinical benefit of semaglutide 2.4 mg
Your medication will then be sent to an address of your choice in discreet packaging
1 Available for when members need emergency or urgent care services while outside their service areas, the BlueCard program will help them locate participating doctors and hospitals, allowing them to receive covered care.